"SARS-CoV-2" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonEarly human embryonic cells may be vulnerable to SARS-CoV-2 infection - University of California,...
Early human embryonic cells may be vulnerable to SARS-CoV-2 infection University of California, Riverside
Understanding the long-term neurological effects of SARS-CoV-2 infection - nature.com
Understanding the long-term neurological effects of SARS-CoV-2 infection nature.com
COVID-19 spreads year round. Here’s how to track it. - The Sick Times
COVID-19 spreads year round. Here’s how to track it. The Sick Times
National Wastewater Data for Respiratory Viruses - Centers for Disease Control and Prevention | C...
National Wastewater Data for Respiratory Viruses Centers for Disease Control and Prevention | CDC (.gov)
Molecular basis of SARS-CoV-2 proofreading enzyme–mediated resistance to remdesivir - PNAS
Molecular basis of SARS-CoV-2 proofreading enzyme–mediated resistance to remdesivir PNAS
Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...
Assessing SARS-CoV-2 Virus Levels in Sewage - U.S. Environmental Protection Agency (.gov)
Assessing SARS-CoV-2 Virus Levels in Sewage U.S. Environmental Protection Agency (.gov)
Statistical crystallography reveals an allosteric network in SARS-CoV-2 Mpro | Communications Bio...
COVID-19 Treatment Clinical Care for Outpatients - Centers for Disease Control and Prevention | C...
COVID-19 Treatment Clinical Care for Outpatients Centers for Disease Control and Prevention | CDC (.gov)
National COVID-19 trends, May 5 - The Sick Times
National COVID-19 trends, May 5 The Sick Times
SARS-CoV-2-derived RNA replicons as safe and effective vaccines - PNAS
SARS-CoV-2-derived RNA replicons as safe and effective vaccines PNAS
Effect of the S2’ site cleavage on SARS-CoV-2 spike - nature.com
Effect of the S2’ site cleavage on SARS-CoV-2 spike nature.com
Staying Up to Date with COVID-19 Vaccines - Centers for Disease Control and Prevention | CDC (.gov)
Staying Up to Date with COVID-19 Vaccines Centers for Disease Control and Prevention | CDC (.gov)
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - nature.com
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade nature.com
Presence of SARS-CoV-2 in fetal organs via intraamniotic infection - nature.com
Presence of SARS-CoV-2 in fetal organs via intraamniotic infection nature.com
SARS-CoV-2 variants: biology, pathogenicity, immunity and control - nature.com
SARS-CoV-2 variants: biology, pathogenicity, immunity and control nature.com
Diagnostic performance evaluation of Elecsys anti-SARS-CoV-2 assay against RT-PCR for SARS-CoV-2 ...
Uncovering potent natural phytochemicals targeting SARS-COV-2 spike protein variants: molecular d...
Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspri...
SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation - nature.com
SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation nature.com
Understanding the COVID-19 Cicada Variant (BA.3.2): Symptoms, Spread and Protection - Stony Brook...
Understanding the COVID-19 Cicada Variant (BA.3.2): Symptoms, Spread and Protection Stony Brook Medicine
Tracing SARS-CoV-2 clusters across local scales using genomic data - PNAS
Tracing SARS-CoV-2 clusters across local scales using genomic data PNAS
New COVID variant with immune escape potential confirmed in US, 22 other countries - CIDRAP
New COVID variant with immune escape potential confirmed in US, 22 other countries CIDRAP
Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of work...
TMPRSS2-mediated coronavirus spike activation and inhibition - nature.com
TMPRSS2-mediated coronavirus spike activation and inhibition nature.com
New coronavirus subspecies with SARS-CoV-2–like mutation discovered in Brazilian bat - CIDRAP
New coronavirus subspecies with SARS-CoV-2–like mutation discovered in Brazilian bat CIDRAP
SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive bindin...
SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive binding PNAS
SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses - PNAS
SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses PNAS
The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies - nature.com
The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies nature.com
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants - PNAS
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants PNAS
Antibodies need a strong core—not just grip—to fight SARS-CoV-2 - Phys.org
Antibodies need a strong core—not just grip—to fight SARS-CoV-2 Phys.org
Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells an...
Hidden plant molecules show up to 25 times stronger activity against Ebola and COVID-19 - Phys.org
Hidden plant molecules show up to 25 times stronger activity against Ebola and COVID-19 Phys.org
Current status and future perspectives on the mechanistic and pathophysiological understanding of...
National flu and COVID-19 surveillance report: 30 April 2026 (week 18) - GOV.UK
National flu and COVID-19 surveillance report: 30 April 2026 (week 18) GOV.UK
PECOS Study: 12-Month Research Tracks Post-COVID-19 Symptoms in Children - geneonline.com
PECOS Study: 12-Month Research Tracks Post-COVID-19 Symptoms in Children geneonline.com
WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)
WHO Scientific advisory group issues report on origins of COVID-19 World Health Organization (WHO)
Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Bination...
Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study | Circulation American Heart Association Journals
Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection - nature.com
Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection nature.com
Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...
Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID Johns Hopkins Medicine
Tracking SARS-CoV-2 variants - World Health Organization (WHO)
Tracking SARS-CoV-2 variants World Health Organization (WHO)
SARS-CoV-2 and COVID-19 - Baylor College of Medicine | BCM
SARS-CoV-2 and COVID-19 Baylor College of Medicine | BCM
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras The New England Journal of Medicine
The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...
Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...
Transmission of SARS-CoV-2: implications for infection prevention precautions World Health Organization (WHO)
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - nature.com
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics nature.com
The proximal origin of SARS-CoV-2 - nature.com
The proximal origin of SARS-CoV-2 nature.com
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern World Health Organization (WHO)
SARS-CoV-2 pathogenesis - nature.com
SARS-CoV-2 pathogenesis nature.com
SARS-CoV-2 infection and persistence in the human body and brain at autopsy - nature.com
SARS-CoV-2 infection and persistence in the human body and brain at autopsy nature.com
Characteristics of SARS-CoV-2 and COVID-19 - nature.com
Characteristics of SARS-CoV-2 and COVID-19 nature.com
Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children - The New England...
Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children The New England Journal of Medicine
Acute and postacute sequelae associated with SARS-CoV-2 reinfection - nature.com
Acute and postacute sequelae associated with SARS-CoV-2 reinfection nature.com
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels nature.com
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - nature.com
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) nature.com
SARS-CoV-2 infection of the oral cavity and saliva - nature.com
SARS-CoV-2 infection of the oral cavity and saliva nature.com
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - The New England Journal...
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 The New England Journal of Medicine
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - nature.com
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo nature.com
SARS-CoV-2 in Animals - aphis.usda.gov
SARS-CoV-2 in Animals aphis.usda.gov
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 - Science | AAAS
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 Science | AAAS
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England - The New England Journa...
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England The New England Journal of Medicine
SARS-CoV-2 Variants and Vaccines - The New England Journal of Medicine
SARS-CoV-2 Variants and Vaccines The New England Journal of Medicine
Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventi...
Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventing the formation of animal reservoirs World Health Organization (WHO)
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection - nature.com
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection nature.com
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults - natur...
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults nature.com
SARS-CoV-2 vaccines in development - nature.com
SARS-CoV-2 vaccines in development nature.com
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 - The New England Journal...
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 The New England Journal of Medicine
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 | MMWR - Centers for D...
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 | MMWR Centers for Disease Control and Prevention | CDC (.gov)
SARS-CoV-2 Variants in Patients with Immunosuppression - The New England Journal of Medicine
SARS-CoV-2 Variants in Patients with Immunosuppression The New England Journal of Medicine
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls - natu...
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls nature.com
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection - The New England...
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection The New England Journal of Medicine
Long COVID after breakthrough SARS-CoV-2 infection - nature.com
Long COVID after breakthrough SARS-CoV-2 infection nature.com
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans - nature.com
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans nature.com
Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages - The New Englan...
Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages The New England Journal of Medicine
Outbreak of SARS-CoV-2 Infections, including COVID-19 ... - Centers for Disease Control and Preve...
Outbreak of SARS-CoV-2 Infections, including COVID-19 ... Centers for Disease Control and Prevention | CDC (.gov)
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - The New England Journal of Medicine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine The New England Journal of Medicine
SARS-CoV-2 evolution during treatment of chronic infection - nature.com
SARS-CoV-2 evolution during treatment of chronic infection nature.com
Spread of SARS-CoV-2 in the Icelandic Population - The New England Journal of Medicine
Spread of SARS-CoV-2 in the Icelandic Population The New England Journal of Medicine
Reducing transmission of SARS-CoV-2 - Science | AAAS
Reducing transmission of SARS-CoV-2 Science | AAAS
SARS-CoV-2 variants, spike mutations and immune escape - nature.com
SARS-CoV-2 variants, spike mutations and immune escape nature.com
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients - The New England Journ...
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients The New England Journal of Medicine
Lab Leak: The True Origins of Covid-19 - The White House (.gov)
Lab Leak: The True Origins of Covid-19 The White House (.gov)
SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows - Centers for Disease Control and Prevention |...
SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows Centers for Disease Control and Prevention | CDC (.gov)
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report - The New England Journal of Medicine
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report The New England Journal of Medicine
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 ...
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses - nature.com
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses nature.com
SARS-CoV-2 Viral Shedding and Rapid Antigen... - Centers for Disease Control and Prevention | CDC...
SARS-CoV-2 Viral Shedding and Rapid Antigen... Centers for Disease Control and Prevention | CDC (.gov)
Real-time environmental surveillance of SARS-CoV-2 aerosols - nature.com
Real-time environmental surveillance of SARS-CoV-2 aerosols nature.com
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing - nature.com
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing nature.com
Birth and Infant Outcomes Following Laboratory ... - Centers for Disease Control and Prevention |...
Birth and Infant Outcomes Following Laboratory ... Centers for Disease Control and Prevention | CDC (.gov)
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents - The New England Journal of Medicine
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents The New England Journal of Medicine
Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr - PNAS
Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr PNAS
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 | Circulation R...
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2 | Circulation Research American Heart Association Journals
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling - PNAS
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling PNAS
SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (.gov)
SARS-CoV-2 fragments may cause problems after infection National Institutes of Health (.gov)
Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences - nature.com
Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences nature.com
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody - nature.com
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody nature.com
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab - The New England J...
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab The New England Journal of Medicine
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase - The New England Jou...
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase The New England Journal of Medicine
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individua...